Biogen BIIB reported its Q4 earnings results on Thursday, February 3, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Biogen missed estimated earnings by 0.29%, reporting an EPS of $3.39 versus an estimate of $3.4, which did not surprise analysts.
Revenue was up $118.60 million from the same period last year.
Also check out this: Alphabet And 4 Other Stocks Sold By Insiders
Past Earnings Performance
Last quarter the company beat on EPS by $0.66, which was followed by a 1.37% increase in the share price the next day.
Here's a look at Biogen's past performance:
Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
---|---|---|---|---|
EPS Estimate | 4.11 | 4.55 | 5.04 | 4.87 |
EPS Actual | 4.77 | 5.68 | 5.34 | 4.58 |
Revenue Estimate | 2.67B | 2.61B | 2.65B | 2.80B |
Revenue Actual | 2.78B | 2.77B | 2.69B | 2.85B |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.